Literature DB >> 28941407

Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease.

Emrin Horgusluoglu-Moloch1, Kwangsik Nho2, Shannon L Risacher3, Sungeun Kim4, Tatiana Foroud5, Leslie M Shaw6, John Q Trojanowski6, Paul S Aisen7, Ronald C Petersen8, Clifford R Jack9, Simon Lovestone10, Andrew Simmons10, Michael W Weiner11, Andrew J Saykin12.   

Abstract

Alzheimer's disease (AD) patients display hippocampal atrophy, memory impairment, and cognitive decline. New neurons are generated throughout adulthood in 2 regions of the brain implicated in AD, the dentate gyrus of the hippocampus and the subventricular zone of the olfactory bulb. Disruption of this process contributes to neurodegenerative diseases including AD, and many of the molecular players in AD are also modulators of adult neurogenesis. However, the genetic mechanisms underlying adult neurogenesis in AD have been underexplored. To address this gap, we performed a gene-based association analysis in cognitively normal and impaired participants using neurogenesis pathway-related candidate genes curated from existing databases, literature mining, and large-scale genome-wide association study findings. A gene-based association analysis identified adenosine A2a receptor (ADORA2A) as significantly associated with hippocampal volume and the association between rs9608282 within ADORA2A and hippocampal volume was replicated in the meta-analysis after multiple comparison adjustments (p = 7.88 × 10-6). The minor allele of rs9608282 in ADORA2A is associated with larger hippocampal volumes and better memory.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADORA2A; Alzheimer's disease; Gene-based association analysis; Hippocampal volume; Memory; NMDA-receptor antagonist; Neurogenesis

Mesh:

Substances:

Year:  2017        PMID: 28941407      PMCID: PMC5774672          DOI: 10.1016/j.neurobiolaging.2017.08.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  56 in total

1.  A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.

Authors:  C Laurent; S Burnouf; B Ferry; V L Batalha; J E Coelho; Y Baqi; E Malik; E Marciniak; E Mariciniak; S Parrot; A Van der Jeugd; E Faivre; V Flaten; C Ledent; R D'Hooge; N Sergeant; M Hamdane; S Humez; C E Müller; L V Lopes; L Buée; D Blum
Journal:  Mol Psychiatry       Date:  2015-07-28       Impact factor: 15.992

Review 2.  A meta-analysis of hippocampal atrophy rates in Alzheimer's disease.

Authors:  Josephine Barnes; Jonathan W Bartlett; Laura A van de Pol; Clement T Loy; Rachael I Scahill; Chris Frost; Paul Thompson; Nick C Fox
Journal:  Neurobiol Aging       Date:  2008-03-17       Impact factor: 4.673

3.  Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

Authors:  B Fischl; M I Sereno; A M Dale
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

4.  Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.

Authors:  Yutaro Komuro; Guixiang Xu; Kiran Bhaskar; Bruce T Lamb
Journal:  Neurobiol Aging       Date:  2015-03-09       Impact factor: 4.673

5.  Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis.

Authors:  Sergio E Baranzini; Radhika Srinivasan; Pouya Khankhanian; Darin T Okuda; Sarah J Nelson; Paul M Matthews; Stephen L Hauser; Jorge R Oksenberg; Daniel Pelletier
Journal:  Brain       Date:  2010-09       Impact factor: 13.501

6.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 7.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Li Shen; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-08-07       Impact factor: 21.566

8.  Adenosine A2A receptor activation is determinant for BDNF actions upon GABA and glutamate release from rat hippocampal synaptosomes.

Authors:  Sandra Henriques Vaz; Sofia Rapaz Lérias; Sara Parreira; Maria José Diógenes; Ana Maria Sebastião
Journal:  Purinergic Signal       Date:  2015-10-09       Impact factor: 3.765

9.  The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).

Authors:  Shannon L Risacher; Sungeun Kim; Li Shen; Kwangsik Nho; Tatiana Foroud; Robert C Green; Ronald C Petersen; Clifford R Jack; Paul S Aisen; Robert A Koeppe; William J Jagust; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Andrew J Saykin
Journal:  Front Aging Neurosci       Date:  2013-04-01       Impact factor: 5.750

Review 10.  Potential implications of a monosynaptic pathway from mossy cells to adult-born granule cells of the dentate gyrus.

Authors:  Helen E Scharfman; Hannah L Bernstein
Journal:  Front Syst Neurosci       Date:  2015-08-19
View more
  23 in total

1.  Deep learning-based identification of genetic variants: application to Alzheimer's disease classification.

Authors:  Taeho Jo; Kwangsik Nho; Paula Bice; Andrew J Saykin
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

2.  Volumetric GWAS of medial temporal lobe structures identifies an ERC1 locus using ADNI high-resolution T2-weighted MRI data.

Authors:  Shan Cong; Xiaohui Yao; Zhi Huang; Shannon L Risacher; Kwangsik Nho; Andrew J Saykin; Li Shen
Journal:  Neurobiol Aging       Date:  2020-07-14       Impact factor: 4.673

3.  Brain Imaging Genomics: Integrated Analysis and Machine Learning.

Authors:  Li Shen; Paul M Thompson
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2019-10-29       Impact factor: 10.961

Review 4.  Astrocytes and Adenosine A2A Receptors: Active Players in Alzheimer's Disease.

Authors:  Cátia R Lopes; Rodrigo A Cunha; Paula Agostinho
Journal:  Front Neurosci       Date:  2021-05-13       Impact factor: 4.677

5.  Identifying genetic risk variants associated with brain volumetric phenotypes via K-sample Ball Divergence method.

Authors:  Yue Hu; Haizhu Tan; Cai Li; Heping Zhang
Journal:  Genet Epidemiol       Date:  2021-06-29       Impact factor: 2.344

6.  Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease.

Authors:  Linhui Xie; Bing He; Pradeep Varathan; Kwangsik Nho; Shannon L Risacher; Andrew J Saykin; Paul Salama; Jingwen Yan
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 13.994

Review 7.  The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease.

Authors:  Lucrezia Cellai; Kevin Carvalho; Emilie Faivre; Aude Deleau; Didier Vieau; Luc Buée; David Blum; Céline Mériaux; Victoria Gomez-Murcia
Journal:  Front Neurosci       Date:  2018-08-03       Impact factor: 4.677

8.  Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors.

Authors:  Mariana Temido-Ferreira; Diana G Ferreira; Vânia L Batalha; Inês Marques-Morgado; Joana E Coelho; Pedro Pereira; Rui Gomes; Andreia Pinto; Sara Carvalho; Paula M Canas; Laetitia Cuvelier; Valerie Buée-Scherrer; Emilie Faivre; Younis Baqi; Christa E Müller; José Pimentel; Serge N Schiffmann; Luc Buée; Michael Bader; Tiago F Outeiro; David Blum; Rodrigo A Cunha; Hélène Marie; Paula A Pousinha; Luísa V Lopes
Journal:  Mol Psychiatry       Date:  2018-06-27       Impact factor: 15.992

9.  Identification of functionally connected multi-omic biomarkers for Alzheimer's disease using modularity-constrained Lasso.

Authors:  Linhui Xie; Pradeep Varathan; Kwangsik Nho; Andrew J Saykin; Paul Salama; Jingwen Yan
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

10.  Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.

Authors:  Emilie Faivre; Joana E Coelho; Katja Zornbach; Enas Malik; Younis Baqi; Marion Schneider; Lucrezia Cellai; Kevin Carvalho; Shéhérazade Sebda; Martin Figeac; Sabiha Eddarkaoui; Raphaëlle Caillierez; Yijuang Chern; Michael Heneka; Nicolas Sergeant; Christa E Müller; Annett Halle; Luc Buée; Luisa V Lopes; David Blum
Journal:  Front Mol Neurosci       Date:  2018-07-12       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.